881
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Opioid overdose knowledge among college students in a high overdose death state

ORCID Icon, , ORCID Icon, &

References

  • Ahmad, F. B., Rossen, L. M., Spencer, M. R., Warner, M., & Sutton, P. (2018). Provisional drug overdose death counts. National Center for Health Statistics.
  • Aid to victim of accident and victim of crime. Immunity from civil liability. West Virginia Code. 55(7A). Retrieved July 16, 2018http://code.wvlegislature.gov/55-7-15/. .
  • Centers for Disease Control and Prevention. (2016). Today’s heroin epidemic.Retrieved November 2, 2018, fromhttp://www.cdc.gov/vitalsigns/heroin/. Published 2016.
  • Centers for Disease Control and Prevention. (2018). Opioid overdose: Understanding the epidemic. Retrieved May 15, 2019, from https://www.cdc.gov/drugoverdose/epidemic/index.html. Published December 19, 2018
  • Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014). A systematic review of community opioid overdose prevention and naloxone distribution programs. Journal of Addiction Medicine., 8(3), 153–163. doi:10.1097/ADM.0000000000000034
  • Davis, C. S., & Carr, D. (2015). Legal changes to increase access to naloxone for opioid overdose reversal in the United States. Drug and Alcohol Dependence, 157, 112–120. doi:10.1016/j.drugalcdep.2015.10.013
  • Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA, 315(15), 1624–1645. doi:10.1001/jama.2016.1464
  • Doyon, S., Aks, S. E., & Schaeffer, S. (2014). Expanding access to naloxone in the United States. Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology, 10, 431–434. doi:10.1007/s13181-014-0432-1
  • Giglio, R. E., Li, G., & DiMaggio, C. J. (2015). Effectiveness of bystander naloxone administration and overdose education programs: A meta-analysis. Injury Epidemiology, 2(1), 10. doi:10.1186/s40621-015-0041-8
  • Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009, Apr). Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381. doi:10.1016/j.jbi.2008.08.010
  • Hedegaard, H., Warner, M., & Minino, A. M. (2017). Drug overdose deaths in the United States, 1999-2016. NCHS Data Brief, 1(294), 1–8.
  • HHS Office of the Secretary,Office. (2018, April 05). U.S. Surgeon general’s advisory on naloxone and opioid overdose. Retrieved from https://www.hhs.gov/surgeongeneral/priorities/opioids-and-addiction/naloxone-advisory/index.html.
  • Holdren, W. (2017, March).Although overdose deaths up, WV health officer cautiously optimistic about future. The Register-Herald, Beckley Register-Herald. Retrieved from http://www.register-herald.com/news/although-overdose-deaths-up-wv-health-officer-cautiously-optimistic-about/article_eb38b7df-09b3-52ac-b3a0-4811c2347f62.html.
  • McCabe, S. E., West, B. T., Teter, C. J., & Boyd, C. J. (2014). Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots. Addictive Behaviors, 39, 1176–1182. doi:10.1016/j.addbeh.2014.03.008
  • National Association of State Alcohol and Drug Abuse Directors. (2019). Single State agency for substance abuse: Resource to check third party prescription laws and Good Samaritan laws. Retrieved from http://nasadad.org/ssa-web-sites/.
  • National Institute on Drug Abuse. (2018, January). Opioid overdose reversal with Naloxone (Narcan, Evzio). Retrieved from https://www.drugabuse.gov/related-topics/opioid-overdosereversal-naloxone-narcan-evzio.
  • Prescription Drug Abuse Policy System. (2017). Naloxone overdose prevention laws. Retrieved from www.pdaps.org.
  • Prevent & Protect, Frequently Asked Questions about Naloxone. (2018). Retrieved from http://prevent-protect.org/individual-resources/faq-individual/.
  • Roberts, J. R. (2014). InFocus: Providing naloxone to non-medical personnel can prevent OD deaths without increasing abuse. Emergency Medicine News, 36, 12–14. doi:10.1097/01.EEM.0000454000.75990.b9
  • Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved overdose deaths—United States, 2013–2017. Morbidity and Mortality Weekly Report, 67(5152), 1419.
  • StataCorp. (2015). Stata statistical software: Release 14. College Station, TX: Author.
  • Substance Abuse and Mental Health Services Administration. SAMHSA opioid overdose prevention toolkit. HHS Publication No. (SMA) 16-4742. Rockville, MD: Author; 2016. Available at https://store.samhsa.gov/system/files/sma18-4742.pdf - PDF.
  • Substance Abuse and Mental Health Services Administration. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National survey on drug use and health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Author. Retrieved from https://www.samhsa.gov/data/.
  • Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., ... & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ (clinical Research Ed.)., 346, f174. doi:10.1136/bmj.f1164
  • Wheeler, E., Jones, T. S., Gilbert, M. K., & Davidson, P. J. (2015). Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014. MMWR, 64, 631–635.
  • Williams, A. V., Strang, J., & Marsden, J. (2013). Development of opioid overdose knowledge (OOKS) and attitudes (OOAS) scales for take-home naloxone training evaluation. Drug and Alcohol Dependence, 132(1–2), 383–386. doi:10.1016/j.drugalcdep.2013.02.007
  • Winstanley, E. L., Clark, A., Feinberg, J., & Wilder, C. M. (2016). Barriers to implementation of opioid overdose prevention programs in Ohio. Substance Abuse, 37(1), 42–46. doi:10.1080/08897077.2015.1132294

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.